Resultats globals: 27 registres trobats en 0.03 segons.
Articles, 27 registres trobats
Articles 27 registres trobats  1 - 10següentfinal  anar al registre:
1.
135 p, 1.9 MB Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias : An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry / Lewczuk, Piotr (University Hospital of Białystok) ; Riederer, Peter (University Hospital Würzburg) ; O'Bryant, Sid E. (University of North Texas Health Science Center) ; Verbeek, Marcel M. (Radboud Alzheimer center) ; Dubois, Bruno (Salpêtrièrie Hospital) ; Visser, Pieter Jelle (Amsterdam Neuroscience VU University Medical Centre) ; Jellinger, Kurt A. (Institute of Clinical Neurobiology) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Ramirez, Alfredo (University of Cologne) ; Parnetti, Lucilla (University of Perugia) ; Jack Jr, Clifford R. (Mayo Clinic) ; Teunissen, Charlotte E. (VU University Medical Center Amsterdam) ; Hampel, Harald (heimer (IM2A). Hôpital Pitié-Salpêtrière) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Jessen, Frank (German Center for Neurodegenerative Disorders (DZNE)) ; Glodzik, Lidia (NYU Langone Medical Center) ; de Leon, Mony J. (NYU Langone Medical Center) ; Fagan, Anne M. (Washington University School of Medicine) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Jansen, Willemijn J. (Maastricht University) ; Winblad, Bengt (Karolinska Institutet (Estocolm, Suècia)) ; Shaw, Leslie M. (University of Pennsylvania) ; Andreasson, Ulf (The Sahlgrenska Academy at the University of Gothenburg) ; Otto, Markus (University of Ulm) ; Mollenhauer, Brit (Kassel and University Medical Center Göttingen) ; Wiltfang, Jens (University of Aveiro) ; Turner, Martin R. (University of Oxford) ; Zerr, Inga (German Center for Neurodegenerative Diseases) ; Handels, Ron (Karolinska Institutet (Estocolm, Suècia)) ; Thompson, Alexander G. (University of Oxford) ; Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ; Ermann, Natalia (Universitätsklinikum Erlangen. and Friedrich-Alexander Universität Erlangen-Nürnberg) ; Trojanowski, John Q. (University of Pennsylvania) ; Karaca, Ilker (University of Bonn) ; Wagner, Holger (University of Bonn) ; Oeckl, Patrick (University of Ulm) ; van Waalwijk van Doorn, Linda (Radboud Alzheimer center) ; Bjerke, Maria (University of Antwerp) ; Kapogiannis, Dimitrios (National Institute on Aging/National Institutes of Health (NIA/NIH)) ; Kuiperij, H.Bea (Radboud Alzheimer center) ; Farotti, Lucia (University of Perugia) ; Li, Yi (NYU Langone Medical Center) ; Gordon, Brian A. (Washington University School of Medicine) ; Epelbaum, Stéphane (Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A)) ; Vos, Stephanie J.B. (Maastricht University) ; Klijn, Catharina J.M. (Radboud Alzheimer Center) ; Van Nostrand, William E. (Stony Brook University) ; Minguillon, Carolina (Fundació Pasqual Maragall) ; Schmitz, Matthias (University Medical School) ; Gallo, Carla (Universidad Peruana Cayetano Heredia) ; Lopez Mato, Andrea (Maimonides University) ; Thibaut, Florence (University Hospital Cochin-Site Tarnier 89 rue d'Assas) ; Lista, Simone (heimer (IM2A). Hôpital Pitié-Salpêtrière) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Kornhuber, Johannes (Universitätsklinikum Erlangen) ; Universitat Autònoma de Barcelona
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. [...]
2018 - 10.1080/15622975.2017.1375556
World Journal of Biological Psychiatry, Vol. 19 Núm. 4 (19 2018) , p. 244-328  
2.
9 p, 745.8 KB The EMIF-AD Multimodal Biomarker Discovery study : Design, methods and cohort characteristics / Bos, Isabelle (Maastricht University) ; Vos, Stephanie (Maastricht University) ; Vandenberghe, Rik (KU Leuven) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Engelborghs, Sebastiaan (University of Antwerp) ; Frisoni, Giovanni (IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José Luis (Fundació Pasqual Maragall) ; Wallin, Anders (Institute of Neuroscience and Physiology) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Lausanne University Hospital) ; Martinez-Lage, Pablo (Centro de Investigación y Tecnología Agroalimentaria de Aragón) ; Baird, Alison (University of Oxford) ; Dobson, Richard (NIHR University College London Hospitals) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, Kristel (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Bertram, Lars (University of Oslo) ; Ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Barkhof, Frederik (Amsterdam UMC. University Medical Center) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford) ; Streffer, Johannes (Janssen Pharmaceutical Companies) ; Visser, Pieter Jelle (Alzheimer Center) ; Universitat Autònoma de Barcelona
There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. [...]
2018 - 10.1186/s13195-018-0396-5
Alzheimer's research & therapy, Vol. 10 Núm. 1 (june 2018) , p. 64  
3.
11 p, 814.5 KB Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals : Examining the Necessity to Adjust for Biomarker Status in Normative Data / Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Maastricht University) ; Jansen, Willemijn J. (Maastricht University) ; Vandenberghe, Rik (KU Leuven) ; Gabel, Silvy (KU Leuven) ; Estanga, Ainara (CITA-Alzheimer Foundation) ; Ecay-Torres, Mirian (CITA-Alzheimer Foundation) ; Tomassen, Jori (Vrije Universiteit Amsterdam) ; den Braber, Anouk (Vrije Universiteit Amsterdam) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Wallin, Anders (University of Gothenburg Sahlgrenska Academy) ; Kettunen, Petronella (University of Oxford) ; Molinuevo, José L. (Universitat Pompeu Fabra) ; Rami, Lorena (Hopsital Clínic Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (IDIBAPS)) ; Chetelat, Gaël (Université de Caen-Normandie GIP Cyceron) ; de la Sayette, Vincent (CHU de Caen) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Freund-Levi, Yvonne (Norrtälje Hospital Tiohundra) ; Johannsen, Peter (University of Copenhagen) ; Novak, Gerald P. (Janssen Pharmaceutical Research and Development) ; Ramakers, Inez (Maastricht University) ; Verhey, Frans R. (Maastricht University) ; Visser, Pieter J. (Vrije Universiteit Amsterdam) ; Universitat Autònoma de Barcelona
We investigated whether amyloid-β (Aβ) and tau affected cognition in cognitively normal (CN) individuals, and whether norms for neuropsychological tests based on biomarker-negative individuals would improve early detection of dementia. [...]
2018 - 10.3389/fnagi.2018.00193
Frontiers in aging neuroscience, Vol. 10 (25 2018) , p. 193  
4.
6 p, 731.5 KB A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood : Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort / Stamate, Daniel (University of London) ; Kim, Min (Steno Diabetes Center Copenhagen) ; Proitsi, Petroula (King's College London) ; Westwood, Sarah (University of Oxford) ; Baird, Alison (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, Abdul (King's College London) ; Bos, Isabelle (Amsterdam UMC) ; Vos, Stephanie J.B. (Maastricht University) ; Vandenberghe, Rik (Amsterdam UMC) ; Teunissen, Charlotte E. (Amsterdam UMC. University Medical Center) ; Kate, Mara Ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill (GlaxoSmithKline R&D) ; De Roeck, Ellen (University of Antwerp) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Bordet, Régis (University of Lille) ; Ramit, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Tainta, Mikel (Fundacion CITA-alzheimer Fundazioa) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José L. (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at the University of Gothenburg) ; Popp, Julius (Geneva University Hospitals) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Bertram, Lars (University of Oslo) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Streffer, Johannes (University of Antwerp) ; Visser, Pieter J. (Amsterdam UMC) ; Lovestone, Simon (Janssen-Cilag UK Ltd) ; Legido-Quigley, Cristina (King's College London) ; Universitat Autònoma de Barcelona
Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers. [...]
2019 - 10.1016/j.trci.2019.11.001
Alzheimer's & dementia, Vol. 5 (2019) , p. 933-938  
5.
11 p, 783.1 KB Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay / Shi, Liu (University of Oxford) ; Westwood, Sarah (University of Oxford) ; Baird, Alison L. (University of Oxford) ; Winchester, Laura (University of Oxford) ; Dobricic, Valerija (University of Lübeck) ; Kilpert, Fabian (University of Lübeck) ; Hong, Shengjun (University of Lübeck) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Hye, Abdul (King's College London) ; Ashton, Nicholas J. (South London and Maudsley NHS Foundation) ; Morgan, Angharad R. (Cardiff University) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Amsterdam UMC. University Medical Center) ; Buckley, Noel J (University of Oxford) ; Kate, Mara ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Engelborghs, Sebastiaan (VUB University Hospital Brussels (UZ Brussel)) ; De Roeck, Ellen E. (Institute Born-Bunge. University of Antwerp) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José L. (Hospital Clínic i Provincial de Barcelona) ; Rami, Lorena (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (University of Oxford) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter Copenhagen University Hospital ; Teunissen, Charlotte E. (Vrije Universiteit) ; Freund-Levi, Yvonne (King's College London) ; Frölich, Lutz (University of Heidelberg) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Barkhof, Frederik (UCL Institutes of Neurology and Healthcare Engineering) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Baker, Susan (Janssen R&D) ; Morgan, B.Paul (Cardiff University) ; Streffer, Johannes (Janssen R&D. LLC) ; Visser, Pieter Jelle (Karolinska Institutet (Estocolm, Suècia)) ; Bertram, Lars (University of Oslo) ; Lovestone, Simon (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Universitat Autònoma de Barcelona
Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. [...]
2019 - 10.1016/j.jalz.2019.06.4951
Alzheimer's & Dementia, Vol. 15 Núm. 11 (november 2019) , p. 1478-1488  
6.
22 p, 986.7 KB Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort / Kim, M. (Steno Diabetes Center Copenhagen) ; Snowden, S. (University of Cambridge) ; Suvitaival, T. (Steno Diabetes Center Copenhagen) ; Ali, A. (Steno Diabetes Center Copenhagen) ; Merkler, D.J. (University of South Florida) ; Ahmad, T. (King's College London) ; Westwood, S. (University of Oxford) ; Baird, A. (University of Oxford) ; Proitsi, P. (King's College London) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, A. (Steno Diabetes Center Copenhagen) ; Bos, I. (Maastricht University) ; Vos, S. (Maastricht University) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Teunissen, C. (Amsterdam Neuroscience) ; ten Kate, M. (Amsterdam Neuroscience) ; Scheltens, P. (Amsterdam UMC. University Medical Center) ; Gabel, Silvy (KU Leuven) ; Meersmans, K. (KU Leuven) ; Blin, Olivier ; Richardson, J. (GlaxoSmithKline R&D) ; De Roeck, E. (University of Antwerp) ; Sleegers, Kristel (VIB) ; Bordet, Régis (University of Lille) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, P. (John Radcliffe Hospital (Oxford, Regne Unit)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, F. (Maastricht University) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, G. (Lausanne University Hospital) ; Tainta, M. (CITA-Alzheimer Foundation) ; Johannsen, P. (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Frölich, L. (University of Heidelberg) ; Dobricic, V. (University of Lübeck) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Frisoni, Giovanni B. (University of Geneva) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Wallin, Anders (University of Gothenburg) ; Popp, J. (Geneva University Hospitals) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Bertram, Lars (University of Lübeck) ; Barkhof, Frederik (Amsterdam Neuroscience) ; Ashton, Nicholas J (University of Gothenburg) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, H. (UK Dementia Research Institute) ; Streffer, J. (Janssen Pharmaceutical Companies) ; Visser, P.J. (Amsterdam Neuroscience) ; Lovestone, S. (University of Oxford) ; Legido-Quigley, C. (Steno Diabetes Center Copenhagen) ; Universitat Autònoma de Barcelona
A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of peripheral small molecule biomarkers. Given that brain pathology precedes clinical symptom onset, we set out to test whether metabolites in blood associated with pathology as indexed by cerebrospinal fluid (CSF) AD biomarkers. [...]
2019 - 10.1016/j.jalz.2019.03.004
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 817-827  
7.
12 p, 1.1 MB Inflammatory biomarkers in Alzheimer's disease plasma / Morgan, Angharad R. (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, Cardiff University (Regne Unit)) ; Touchard, Samuel (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University (Regne Unit)) ; Leckey, Claire A. (Cardiff University (Regne Unit)) ; O'Hagan, Caroline (Cardiff University (Regne Unit)) ; Nevado-Holgado, Alejo (University of Oxford (Regne Unit)) ; Barkhof, Frederik (University College London) ; Bertram, Lars (Max Planck Institute for Molecular Genetics (Alemanya)) ; Blin, Olivier (Aix-Marseille University (França)) ; Bos, Isabelle (Maastricht University (Països Baixos)) ; Dobricic, Valerija (University of Lübeck (Alemanya)) ; Engelborghs, Sebastiaan (Institute Born-Bunge (Bèlgica)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (Brescia, Itàlia)) ; Froelich, Lutz (University of Heidelberg (Alemanya)) ; Gabel, Silvy (Laboratory for Cognitive Neurology (Leuven, Bèlgica)) ; Johannsen, Peter (Karolinska Institutet (Stockholm, Sweden)) ; Kettunen, Petronella (University of Gothenburg (Gothenburg, Suècia)) ; Kłoszewska, Iwona (Medical University of Lodz (Lodz, Poland)) ; Legido-Quigley, Cristina (Imperial College London) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Martinez-Lage, Pablo (Fundación CITA-Alzheimer Fundazioa (San Sebastian, Spain)) ; Mecocci, Patrizia (University of Perugia (Itàlia)) ; Meersmans, Karen (Laboratory for Cognitive Neurology (Bèlgica)) ; Molinuevo, José Luis (Universitat Pompeu Fabra) ; Peyratout, Gwendoline (Lausanne University Hospital (Suïssa)) ; Popp, Julius (Hopitaux Universitaires Geneve and Universite de Geneve (Suïssa)) ; Richardson, Jill (GlaxoSmithKline R&D (Regne Unit)) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Scheltens, Philip (Vrije Universiteit (Països Baixos)) ; Streffer, Johannes (University of Antwerp) ; Soininen, Hikka (University of Eastern Finland) ; Tainta, Mikel (Fundación CITA Alzheimer (Sant Sebastià, País Basc)) ; Teunissen, Charlotte E (University Hospitals Leuven (Bèlgica)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Vandenberghe, Rik (Amsterdam University Medical Centers (Països Baixos)) ; Visser, Pieter Jelle (Maastricht University (Països Baixos)) ; Vos, Stephanie (Maastricht University (Països Baixos)) ; Wahlund, Lars Olof (Karolinska Institutet (Estocolm, Suècia)) ; Wallin, Anders (University of Gothenburg Sahlgrenska Academy) ; Westwood, Sarah (University of Oxford (Regne Unit)) ; Zetterberg, Henrik (UK Dementia Research Institute (Londres, Regne Unit)) ; Lovestone, Simon (University of Oxford (Regne Unit)) ; Morgan, B. Paul (Cardiff University (Regne Unit)) ; Bullmore, Edward (University of Cambridge (Regne Unit)) ; Bhatti, Junaid (University of Cambridge (Regne Unit)) ; Chamberlain, Samuel J. (University of Cambridge (Regne Unit)) ; Correia, Marta Morgado (University of Cambridge (Regne Unit)) ; Crofts, Anna L. (Université de Sherbrooke (Canadà)) ; Dickinson, Amber (Addenbroke's Hospital (Cambridge, Regne Unit)) ; Foster, Andy C. (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ; Kitzbichler, Manfred G. (University of Cambridge (Regne Unit)) ; Knight, Clare (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ; Lynall, Mary-Ellen (University of Cambridge (Regne Unit)) ; Maurice, Christina (University of Cambridge (Regne Unit)) ; O'Donnell, Ciara M. (University College London (Regne Unit)) ; Pointon, Linda J. (University of Cambridge (Regne Unit)) ; St George Hyslop, Peter (University of Cambridge (Regne Unit)) ; Turner, Lorinda (University of Cambridge (Regne Unit)) ; Vertes, Petra E. (University of Cambridge (Regne Unit)) ; Widmer, Barry (University of Cambridge (Regne Unit)) ; Williams, Guy (University of Cambridge (Regne Unit)) ; Cavanagh, Jonathan T. O. (Karolinska Institutet (Suècia)) ; Deith, Catherine (Southern General Hospital Glasgow (Escòcia)) ; Farmer, Scott (Bio Med Sciences Inc.(Galveston, Estats Units)) ; McClean, John (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ; McColl, Alison (College of Medical, Veterinary & Life Sciences (Glasgow, Escòcia)) ; McPherson, Andrew (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Scouller, Paul (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Sutherland, Murray (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ; Boddeke, Erik W.G.M. (Københavns UniversitetThe institution (Copenhaguen, Dinamarca)) ; Khan, Shahid (GlaxoSmithKline plc. (Regne Unit)) ; Murphy, Philip Stephen (GlaxoSmithKline plc. (Regne Unit)) ; Parker, Christine A. (Wellcome Trust (Londres, Regne Unit)) ; Patel, Jai (GlaxoSmithKline plc. (Regne Unit)) ; Jones, Declan (Janssen Pharmaceuticals (Titusville, Estats Units)) ; de Boer, Peter (Janssen Research & Development (Beerse, Bèlgica)) ; Kemp, John A. (KU Leuven- University Hospital Leuven (Bèlgica)) ; Drevets, Wayne Curtis (Janssen Research & Development (Beerse, Bèlgica)) ; Nye, Jeffrey S. (Janssen Research & Development (Beerse, Bèlgica)) ; Wittenberg, Gayle M. (Janssen Research & Development (Beerse, Bèlgica)) ; Isaac, John T.R. (Johnson & Johnson (Estats Units)) ; Bhattacharya, Anindya (Janssen Research & Development (Beerse, Bèlgica)) ; Carruthers, Niicholas L. (Janssen Research & Development (Beerse, Bèlgica)) ; Kolb, Hartmuth Christian (Janssen Research & Development (Beerse, Bèlgica)) ; Pariante, Carmine M. (King's College London (Regne Unit)) ; Turkheimer, Federico (King's College London (Regne Unit)) ; Barker, Gareth John (King's College London (Regne Unit)) ; Byrom, Heidi (King's College London (Regne Unit)) ; Cash, Diana (King's College London (Regne Unit)) ; Cattaneo, Annamaria (King's College London (Regne Unit)) ; Gee, Anthony (King's College London (Regne Unit)) ; Hastings, Caitlín N.M. (King's College London (Regne Unit)) ; Mariani, Nicole (King's College London (Regne Unit)) ; McLaughlin, Anna Patricia (King's College London (Regne Unit)) ; Mondelli, Valeria (King's College London (Regne Unit)) ; Nettis, Maria Antonietta (King's College London (Regne Unit)) ; Nikkheslat, Naghmeh (King's College London (Regne Unit)) ; Randall, Karen (King's College London (Regne Unit)) ; Sheridan, Hannah C. (King's College London (Regne Unit)) ; Simmons, Camilla (King's College London (Regne Unit)) ; Singh, Nisha (King's College London (Regne Unit)) ; Van Loo, Victoria (King's College London (Regne Unit)) ; Vicente-Rodríguez, Marta (King's College London (Regne Unit)) ; Wood, Tobias (King's College London (Regne Unit)) ; Worrell, Courtney (King's College London (Regne Unit)) ; Zajkowska, Zuzanna (King's College London (Regne Unit)) ; Plath, Niels (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Egebjerg, Jan (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Eriksson, Hans (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Gastambide, Francois (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Adams, Karen Husted (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Jeggo, Ross D. (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Thomsen, Christian (Aalborg Universitetshospital (Aalborg, Dinamarca)) ; Pederson, Jan Torleif (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Campbell, Brian M. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; Möller, Thomas (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; Nelson, Bob (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Zorn, Stevin H. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; O'Connor, Jason (University of Texas Hlth Sci Ctr San Antonio(Estats Units)) ; Attenburrow, Mary Jane (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Baird, Alison (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Benjamin, Jithen (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Clare, Stuart (John Radcliffe Hosp, Oxford Ctr Funct MRI Brain (Oxford, Anglaterra)) ; Cowen, Philip (University of Oxford (Anglaterra)) ; Huang, I-Shuo Wade (Kennedy Inst Rheumatol (Oxford, Anglaterra)) ; Hurley, Samuel A. (University of Wisconsin-Madison (Madison, Estats Units)) ; Jones, Helen (Warneford Hosp, NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Mada, Francisca (Neurosciences & Neurology) ; Nevado-Holgado, Alejo (University of Oxford (Anglaterra)) ; Oladejo, Akitayo (Metropolitan Hospital Center (New York, Estats Units)) ; Ribe, Elena (King's College London (Londres, Anglaterra)) ; Smith, Katy (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Vyas, Anviti (University of Oxford (Oxford, Anglaterra)) ; Hughes, Zoe (Praxis Precision Medicines (Cambridge, Regne Unit)) ; Balice-Gordon, Rita (Sanofi S.A. (Gentilly, França)) ; Duerr, James M. (Pfizer Inc.(New York, Estats Units)) ; Piro, Justin R. (Pfizer Inc.(New York, Estats Units)) ; Sporn, Jonathan (Gilgamesh Pharmaceut (New York, Estats Units)) ; Perry, V. Hugh (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Cleal, Madeleine (University of Portsmouth (Anglaterra)) ; Fryatt, Gemma (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Gomez-Nicola, Diego (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Mancuso, Renzo (University of Southampton (Anglaterra)) ; Reynolds, Richard (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Harrison, Neil (University fo Sussex (Brighton, Anglaterra)) ; Cercignani, Mara (University fo Sussex (Brighton, Anglaterra)) ; Clarke, Charlotte L. (University of Sussex (Brighton, Regne Unit)) ; Hoskins, Elizabeth (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ; Kohn, Charmaine (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ; Murray, Rosemary (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Wilcock, Lauren (Sussex Partnership NHS Fdn Trust (Hove, Anglaterra)) ; Wlazly, Dominika (Brighton and Sussex University Hospitals NHS Trust (Sussex, Anglaterra)) ; Mount, Howard T.J. (University of Toronto (Toronto, Canadà)) ; Universitat Autònoma de Barcelona
Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers. A hypothesis-led plasma biomarker search was conducted in the context of international multicenter studies. [...]
2019 - 10.1016/j.jalz.2019.03.007
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 776-787  
8.
13 p, 162.5 KB Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort / Westwood, S. (University of Oxford) ; Baird, Alison L (University of Oxford) ; Anand, S.N. (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Kormilitzin, A. (University of Oxford) ; Shi, L. (University of Oxford) ; Hye, A. (King's College London) ; Ashton, Nicholas J (University of Gothenburg) ; Morgan, A.R. (Cardiff University) ; Bos, I. (Maastricht University) ; Vos, S.J.B. (Maastricht University) ; Baker, S. (Janssen R and D) ; Buckley, Noel J (University of Oxford) ; Ten Kate, M. (Vu University Medical Center) ; Scheltens, P. (Vu University Medical Center) ; Teunissen, C.E. (Vu University Medical Center) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Ku Leuven) ; Meersmans, K. (Ku Leuven) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; De Roeck, E.E. (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology) ; Frisoni, Giovanni B. (Irccs Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, J.C. (GlaxoSmithKline R and D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami, L. (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, P. (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, F. (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, J. (Geneva University Hospitals) ; Peyratout, G. (Lausanne University Hospital) ; Martinez-Lage, P. (Geneva University Hospitals) ; Tainta, M. (CITA-Alzheimer Foundation) ; Johannsen, P. (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, L. (University of Heidelberg) ; Dobricic, V. (University of Lübeck) ; Legido-Quigley, C. (Steno Diabetes Center) ; Bertram, Lars (University of Oslo) ; Barkhof, Frederik (Ucl Institutes of Neurology and Healthcare Engineering) ; Zetterberg, H. (Ucl Institute of Neurology) ; Morgan, B.P. (Cardiff University) ; Streffer, J. (Janssen R and D. Llc) ; Visser, P.J. (Vu University Medical Center) ; Lovestone, S. (Janssen R and D) ; Universitat Autònoma de Barcelona
We have previously investigated, discovered, and replicated plasma protein biomarkers for use to triage potential trials participants for PET or cerebrospinal fluid measures of Alzheimer's disease (AD) pathology. [...]
2020 - 10.3233/JAD-190434
Journal of Alzheimer's disease, Vol. 74 Núm. 1 (2020) , p. 213-225  
9.
12 p, 1.3 MB Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset / Hong, S. (University of Lübeck) ; Prokopenko, D. (Massachusetts General Hospital) ; Dobricic, V. (University of Lübeck) ; Kilpert, F. (University of Lübeck) ; Bos, I. (Vrije Universiteit Amsterdam) ; Vos, S.J.B. (Maastricht University) ; Tijms, Betty M (Vrije Universiteit Amsterdam) ; Andreasson, Ulf (Sahlgrenska University Hospital (Suècia)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Cleynen, I. (KU Leuven) ; Gabel, Silvy (KU Leuven) ; Schaeverbeke, J. (KU Leuven) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, C.E. (Vrije Universiteit) ; Niemantsverdriet, E. (University of Antwerp) ; Engelborghs, Sebastiaan (UZ Brussel and Vrije Universiteit Brussel (VUB)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, J.C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, P. (University of Oxford) ; Wallin, Anders (University of Gothenburg) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, J. (Lausanne University Hospital) ; Peyratout, G. (Lausanne University Hospital) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Tainta, M. (CITA-Alzheimer Foundation) ; Dobson, R.J.B. (University College London) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, K. (University of Antwerp) ; Van Broeckhoven, C. (University of Antwerp) ; ten Kate, M. (Amsterdam Neuroscience) ; Barkhof, Frederik (University College London) ; Zetterberg, H. (UK Dementia Research Institute) ; Lovestone, S. (University of Oxford) ; Streffer, J. (UCB Biopharma SPRL) ; Wittig, M. (Christian-Albrechts-University of Kiel) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Tanzi, R.E. (Massachusetts General Hospital) ; Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ; Bertram, Lars (University of Oslo) ; Universitat Autònoma de Barcelona
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. [...]
2020 - 10.1038/s41398-020-01074-z
Translational psychiatry, Vol. 10 Núm. 1 (december 2020) , p. 403  
10.
11 p, 1.4 MB APOE ϵ4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease / Konijnenberg, E. (Alzheimer Center Amsterdam) ; Tijms, Betty M (Alzheimer Center Amsterdam) ; Gobom, J. (University of Gothenburg) ; Dobricic, V. (University of Lübeck) ; Bos, Isabelle (Maastricht University) ; Vos, S. (Maastricht University) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, F. (Maastricht University) ; Popp, J. (Lausanne University Hospital) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Frölich, L. (University of Heidelberg) ; Lovestone, S. (Janssen RandD) ; Streffer, J. (Janssen RandD) ; Bertram, Lars (University of Oslo) ; Blennow, Kaj (University of Gothenburg) ; Teunissen, C.E. (Vrije Universiteit Amsterdam) ; Veerhuis, R. (Vrije Universiteit Amsterdam) ; Smit, A.B. (Vrije Universiteit Amsterdam) ; Scheltens, P. (Vrije Universiteit Amsterdam) ; Zetterberg, H. (UK Dementia Research Institute) ; Visser, P.J. (Karolinska Instutet) ; Universitat Autònoma de Barcelona
Aggregation of amyloid β into plaques in the brain is one of the earliest pathological events in Alzheimer's disease (AD). The exact pathophysiology leading to dementia is still uncertain, but the apolipoprotein E (APOE) ϵ4 genotype plays a major role. [...]
2020 - 10.1186/s13195-020-00628-z
Alzheimer's research & therapy, Vol. 12 Núm. 1 (27 2020) , p. 65  

Articles : 27 registres trobats   1 - 10següentfinal  anar al registre:
Vegeu també: autors amb noms similars
1 Visser, Jenny A.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.